A detailed history of Natixis Investment Managers International transactions in Eli Lilly & CO stock. As of the latest transaction made, Natixis Investment Managers International holds 117,911 shares of LLY stock, worth $93.8 Million. This represents 7.53% of its overall portfolio holdings.

Number of Shares
117,911
Previous 121,792 3.19%
Holding current value
$93.8 Million
Previous $110 Million 5.27%
% of portfolio
7.53%
Previous 8.25%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $3 Million - $3.73 Million
-3,881 Reduced 3.19%
117,911 $104 Million
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $3.86 Million - $4.84 Million
5,324 Added 4.57%
121,792 $110 Million
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $112,518 - $150,533
190 Added 0.16%
116,468 $90.6 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $23,108 - $27,241
44 Added 0.04%
116,278 $67.8 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $104,762 - $144,431
-241 Reduced 0.21%
116,234 $62.4 Million
Q2 2023

Aug 11, 2023

BUY
$350.74 - $468.98 $3.43 Million - $4.59 Million
9,787 Added 9.17%
116,475 $54.6 Million
Q1 2023

May 12, 2023

SELL
$310.63 - $364.82 $204,394 - $240,051
-658 Reduced 0.61%
106,688 $36.6 Million
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $795,193 - $926,558
-2,473 Reduced 2.25%
107,346 $39.3 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $153 Million - $175 Million
-517,143 Reduced 82.48%
109,819 $35.9 Million
Q2 2022

Aug 12, 2022

BUY
$278.73 - $327.27 $4.79 Million - $5.63 Million
17,196 Added 2.82%
626,962 $203 Million
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $120 Million - $149 Million
510,552 Added 514.6%
609,766 $175 Million
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $224,850 - $279,040
-1,000 Reduced 1.0%
99,214 $27.5 Million
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $107,919 - $132,809
-487 Reduced 0.48%
100,214 $23.3 Million
Q2 2021

Aug 13, 2021

BUY
$180.55 - $233.54 $1.35 Million - $1.74 Million
7,454 Added 7.99%
100,701 $23.2 Million
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $1.33 Million - $1.72 Million
8,097 Added 9.51%
93,247 $17.3 Million
Q4 2020

Feb 12, 2021

SELL
$130.46 - $172.63 $80,885 - $107,030
-620 Reduced 0.72%
85,150 $14.2 Million
Q3 2020

Nov 12, 2020

SELL
$146.22 - $169.13 $24,857 - $28,752
-170 Reduced 0.2%
85,770 $12.6 Million
Q2 2020

Aug 13, 2020

BUY
$136.42 - $164.18 $3.39 Million - $4.08 Million
24,850 Added 40.68%
85,940 $14 Million
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $369,055 - $456,785
-3,100 Reduced 4.83%
61,090 $8.37 Million
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $444,787 - $550,908
-4,160 Reduced 6.09%
64,190 $8.42 Million
Q3 2019

Nov 13, 2019

SELL
$106.79 - $116.16 $92,907 - $101,059
-870 Reduced 1.26%
68,350 $7.68 Million
Q2 2019

Aug 13, 2019

BUY
$110.79 - $129.32 $1.18 Million - $1.37 Million
10,610 Added 18.1%
69,220 $7.74 Million
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $47,863 - $56,338
-430 Reduced 0.73%
58,610 $7.56 Million
Q4 2018

Feb 14, 2019

SELL
$105.9 - $118.64 $1.99 Million - $2.23 Million
-18,797 Reduced 24.15%
59,040 $6.75 Million
Q3 2018

Nov 14, 2018

SELL
$85.86 - $107.31 $808,887 - $1.01 Million
-9,421 Reduced 10.8%
77,837 $8.32 Million
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $771,685 - $885,654
-10,194 Reduced 10.46%
87,258 $7.52 Million
Q1 2018

May 15, 2018

BUY
$74.21 - $87.6 $2.93 Million - $3.46 Million
39,472 Added 68.08%
97,452 $7.55 Million
Q4 2017

Feb 14, 2018

SELL
$81.94 - $87.89 $1.13 Million - $1.22 Million
-13,832 Reduced 19.26%
57,980 $4.94 Million
Q3 2017

Nov 14, 2017

SELL
$77.07 - $85.54 $350,514 - $389,035
-4,548 Reduced 5.96%
71,812 $6.12 Million
Q2 2017

Aug 14, 2017

BUY
N/A
76,360
76,360 $6.33 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Natixis Investment Managers International Portfolio

Follow Natixis Investment Managers International and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Investment Managers International, based on Form 13F filings with the SEC.

News

Stay updated on Natixis Investment Managers International with notifications on news.